期刊
CANCER LETTERS
卷 250, 期 2, 页码 292-299出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.canlet.2006.10.011
关键词
TP53; BCL-2; BAX; bladder cancer
类别
Whether TP53, BCL-2 and BAX expressions add independent prognostic information in patients with Ta/Tlbladder urothelial carcinoma remains unclear. TP53 overexpression correlated with high tumor grade (p = 0.004), WHO grading categories (0.045), BAX expression (p = 0.043) and pathologic stage (p = 0.05). BCL-2 immunostaining was inverse associated with tumor grade (p = 0.008). Lack of BAX expression was related to reduced patient's survival (p = 0.028). Mortality was higher in patients with BCL-2+/TP53+ (p = 0.023) or TP53+/BAX- (p = 0.027) phenotype. BAX and pathologic stage were independent predictors of progression-free and overall survival, respectively. Therefore, BAX expression might be relevant in patient's prognosis. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据